 |
JHP Pharmaceuticals to Produce
Clinical and Commercial Supply of an Innovative
Injectable
PARSIPPANY, NJ June 05, 2012 -- JHP
Pharmaceuticals, a provider of global contract
manufacturing services for sterile products has
entered into an agreement with an undisclosed
pharmaceutical company to produce clinical and
commercial supply of an innovative injectable used
in the cardiovascular setting.
Stuart Hinchen
president and CEO of JHP stated, “We are pleased to
serve this important customer and recognize that
being selected to produce this injectable is based
on our expertise with complex formulations coupled
with our competence in both clinical supply and
commercial supply.”
Hinchen noted, “JHP’s extensive experience
working with products through their life cycle
starting with clinical trials through approval,
product launch and global commercialization provides
customers with a measure of confidence allowing them
to focus on their day-to-day business priorities.”
JHP’s Rochester, Michigan manufacturing site’s
25-year history in contract manufacturing is a
result of a solid cGMP compliance record, a
quality-driven experienced staff and a
customer-centric approach.
About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New
Jersey, provides contract manufacturing of sterile
products including biologics, small molecule,
controlled substances, vaccines, ophthalmics, otics
and antibiotics for large and small pharmaceutical
and biotech organizations.
JHP’s sterile manufacturing facility, located in Rochester Michigan sits
on over 80 acres of land and includes a 171,000 sq.
ft. production building and warehouse. The
production facility utilizes three high-speed
filling lines, a clinical filling line and four
lyophilizers. The site also includes separate
facilities for chemistry, sterility testing, and
analytical methods development.
JHP has the capability to manufacture small-scale clinical through
large-scale commercial products. JHP employs more
than 370 staff in the USA in its manufacturing,
product development, regulatory, sales and marketing
and corporate areas. For more information, please
visit
www.jhppharma.com.
|
|
|
|
Additional Press Releases |
|
|
|
04/17/13 |
|
JHP Pharmaceuticals To Produce Supplies of Biologic Drug Product For Late-Phase Clinical Trials |
 |
|
Webpage
|
PDF Format |
|
|
|
|
09/19/12 |
|
JHP Pharmaceuticals To Produce
Lyophilized Biologic for International
Late-Phase Clinical Trials
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/05/12 |
|
JHP Pharmaceuticals to Produce
Clinical and Commercial Supply of an
Innovative Injectable |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
02/29/12 |
|
JHP Pharmaceuticals Adds Second Product To Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/25/11 |
|
JHP Pharmaceuticals to Produce
Clinical Batches of Innovative Cardiac
Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/06/11 |
|
JHP Pharmaceuticals Enters Agreement
To Produce Life-Saving Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/05/11 |
|
JHP Pharmaceuticals Launches New
Multipack Presentations of Adrenalin®,
Coly-Mycin® M and Pitocin® |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/24/11 |
|
JHP Pharmaceuticals Announces Chief
Executive Officer Succession |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
03/28/11 |
|
JHP Pharmaceuticals Announces
Multi-Year Contract Manufacturing
Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
02/24/11 |
|
JHP Pharmaceuticals Enters Another Multi-Year
Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
01/27/11 |
|
JHP Pharmaceuticals & Putney Inc. Announce
Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/29/10 |
|
JHP Pharmaceuticals Announces Multi-Year
Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
05/10/10 |
|
JHP Pharmaceuticals Announces Successful
Completion of FDA and EMEA GMP Audits |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
09/28/09 |
|
JHP Announces FDA
Approval for Dantrium
IV, rapidly mixing in 20
seconds
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
08/20/08 |
|
JHP Pharmaceuticals &
SpePharm complete
purchaseof Dantrium®
(dantrolene sodium)
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/16/07 |
|
King Pharmaceuticals Completes Sale
Of Rochester, Michigan Manufacturing
Facility To JHP Pharmaceuticals |
|
|
|
Webpage
|
PDF Format |
|
|
|
Return To Press Releases
»
|
 |
To contact JHP Pharmaceuticals regarding
product information or general
questions, please
Contact Us
»
Request additional information about JHP
Pharmaceuticals or product information.
Information Request
»
|
|
